BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34994589)

  • 1. Novel Finding of Copy Number Gains in GNAS and Loss of 10q in a Child With Malignant Transformation of Neurocutaneous Melanosis Syndrome.
    Peterson C; Toll SA; Kolb B; Poulik JM; Reyes-Mugica M; Sood S; Haridas A; Wang ZJ; Marupudi NI
    JCO Precis Oncol; 2021 Nov; 5():33-38. PubMed ID: 34994589
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and therapeutic approach for neurocutaneous melanosis in a young adult.
    Alessandro L; Blaquier JB; Bártoli J; Diez B
    Neurologia (Engl Ed); 2019 Jun; 34(5):336-338. PubMed ID: 27939117
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.
    Schaff LR; Marghoob A; Rosenblum MK; Meyer R; Khakoo Y
    Pediatr Dermatol; 2019 Jul; 36(4):497-500. PubMed ID: 30868657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number abnormalities in new or progressive 'neurocutaneous melanosis' confirm it to be primary CNS melanoma.
    Kinsler VA; Polubothu S; Calonje JE; Chong WK; Thompson D; Jacques TS; Morrogh D
    Acta Neuropathol; 2017 Feb; 133(2):329-331. PubMed ID: 27933403
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of neurocutaneous melanosis and neuroimaging findings.
    Gocmen R; Guler E; Arslan EA
    J Radiol Case Rep; 2015 Mar; 9(3):1-6. PubMed ID: 25926927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.
    van Engen-van Grunsven AC; Rabold K; Küsters-Vandevelde HV; Rijntjes J; Djafarihamedani M; Hehir-Kwa JY; Küsters B; Willemsen MA; van der Burgt I; Wesseling P; Blokx WA; Groenen PJ
    Acta Neuropathol; 2017 Feb; 133(2):333-335. PubMed ID: 27988846
    [No Abstract]   [Full Text] [Related]  

  • 7. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 8. New insights into neurocutaneous melanosis.
    Jakchairoongruang K; Khakoo Y; Beckwith M; Barkovich AJ
    Pediatr Radiol; 2018 Nov; 48(12):1786-1796. PubMed ID: 30074086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Follow-Up of Patients with Neurocutaneous Melanosis in a Tertiary Center; Proposed Modification in Diagnostic Criteria.
    Habibi Z; Ebrahimi H; Meybodi KT; Yaghmaei B; Nejat F
    World Neurosurg; 2021 Feb; 146():e1063-e1070. PubMed ID: 33246180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.
    Sharouf F; Zaben M; Lammie A; Leach P; Bhatti MI
    Childs Nerv Syst; 2018 Aug; 34(8):1471-1477. PubMed ID: 29948137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocutaneous melanosis.
    Burstein F; Seier H; Hudgins PA; Zapiach L
    J Craniofac Surg; 2005 Sep; 16(5):874-6. PubMed ID: 16192875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age related changes in brain MR appearance in the course of neurocutaneous melanosis.
    Bekiesińska-Figatowska M; Sawicka E; Żak K; Szczygielski O
    Eur J Radiol; 2016 Aug; 85(8):1427-31. PubMed ID: 27423683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for GNAS copy number variants in patients with features of Albright's hereditary osteodystrophy and abnormal platelet Gs activity.
    Izzi B; de Zegher F; Francois I; del Favero J; Goossens D; Wittevrongel C; Thys C; Van Geet C; Freson K
    J Hum Genet; 2012 Apr; 57(4):277-9. PubMed ID: 22277900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS-mutant neurocutaneous melanosis.
    Schweizer L; Hartmann W; Koch A; Nunninger M; Thomale UW; Pennacchietti V; Tietze A; Horn D; Pajtler KW; Hirsch S; Wieland I; Deubzer H; Rossi R; Driever PH; von Hoff K; von Zezschwitz B
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12830. PubMed ID: 35728810
    [No Abstract]   [Full Text] [Related]  

  • 15. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
    Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
    Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
    [No Abstract]   [Full Text] [Related]  

  • 16. Spinal neurocutaneous melanosis without cutaneous nevi.
    Asanuma K; Kasai Y; Takegami K; Ito H; Yoshikawa T; Uchida A
    Spine (Phila Pa 1976); 2008 Oct; 33(21):E798-801. PubMed ID: 18827686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asymptomatic neonatal neurocutaneous melanosis].
    Abbo O; Dubedout S; Ballouhey Q; Maza A; Sevely A; Galinier P
    Arch Pediatr; 2012 Dec; 19(12):1319-21. PubMed ID: 23107087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Melanocytic Nevus Syndrome: A Case Series.
    Recio A; Sánchez-Moya AI; Félix V; Campos Y
    Actas Dermosifiliogr; 2017 Nov; 108(9):e57-e62. PubMed ID: 28110826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse leptomeningeal hyperintensity on fluid-attenuated inversion recovery MR images in neurocutaneous melanosis.
    Hayashi M; Maeda M; Maji T; Matsubara T; Tsukahara H; Takeda K
    AJNR Am J Neuroradiol; 2004 Jan; 25(1):138-41. PubMed ID: 14729544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocutaneous melanosis.
    Di Rocco F; Sabatino G; Koutzoglou M; Battaglia D; Caldarelli M; Tamburrini G
    Childs Nerv Syst; 2004 Jan; 20(1):23-8. PubMed ID: 14576958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.